Diligence memo · auto-generated · as of July 2, 2026

US-Hetian Supplement Int'l, Inc.

US-Hetian Supplement Int'l, Inc. looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

US-Hetian Supplement Int'l, Inc. operates in Other Health Care, based in San Marino.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

US-Hetian Supplement Int'l, Inc. has raised $1.4M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $1.4M on 2010-06-01.

Most recent recorded round closed around 2010-06-01.

Valuation (modeled)modeled

Provath models US-Hetian Supplement Int'l, Inc. at approximately $34M (range $1.2M–$266M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.85× the median modeled value of Seed Other Health Care companies in 2010–2012 (243 peers) — value vs value, same stage and era. Within the normal band (85% of peer median) for its niche.

Financing rhythm & timingmixed

Last raise 16.1 yr ago; this sector typically re-raises about every 14 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 40% of Other Health Care peers (5377 compared).

Modeled value ranks above 61% of those peers.

Closest niche peers: Coolsystems Inc, Device Innovation Group, LLC, Envoy Partners Llc, Kare Partners LLC, CuMed LLC.

Peoplefiled

4 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.